A major breakthrough in cancer investigation is arising with the use of VHH fragments to re-engage mutated p53. This essential malignant protector protein is frequently inactivated in several kinds of tumors, resulting https://bookmarkangaroo.com/story22100810/mini-antibodies-revive-the-p53-protein-a-new-approach-for-tumor-management